CARIS LIFE SCIENCES INC (CAI) Forecast, Price Target & Analyst Ratings

NASDAQ:CAIUS1421521071

Current stock price

21.15 USD
+0.75 (+3.68%)
At close:
21.15 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARIS LIFE SCIENCES INC (CAI).

Forecast Snapshot

Consensus Price Target

Price Target
$32.92
+ 55.64% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.02
Revenue Estimate
212.39M

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$32.92
Upside
+ 55.64%
From current price of $21.15 to mean target of $32.92, Based on 14 analyst forecasts
Low
$22.22
Median
$35.70
High
$39.90

Price Target Revisions

1 Month
-12.06%
3 Months
-14.82%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for CAI. The average price target is 32.92 USD. This implies a price increase of 55.64% is expected in the next year compared to the current price of 21.15.
The average price target has been revised downward by 14.82% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CAI Current Analyst RatingCAI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

CAI Historical Analyst RatingsCAI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
CAI was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CAI.
In the previous month the buy percentage consensus was at a similar level.
CAI was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-13JefferiesInitiate Buy
2026-04-10Piper SandlerInitiate Neutral
2026-04-06Evercore ISI GroupMaintains Outperform -> Outperform
2026-03-13Canaccord GenuityMaintains Hold -> Hold
2026-02-27BTIGMaintains Buy -> Buy
2026-02-27Evercore ISI GroupMaintains Outperform -> Outperform
2026-02-27BairdMaintains Outperform -> Outperform
2026-02-17BairdInitiate Outperform
2025-12-22Canaccord GenuityMaintains Hold -> Hold
2025-12-02Canaccord GenuityInitiate Hold
2025-08-13GuggenheimMaintains Buy -> Buy
2025-08-13Evercore ISI GroupMaintains Outperform -> Outperform
2025-08-13CitigroupMaintains Buy -> Buy
2025-07-15Evercore ISI GroupInitiate Outperform
2025-07-14TD CowenInitiate Buy
2025-07-14GuggenheimInitiate Buy
2025-07-14Wolfe ResearchInitiate Outperform
2025-07-14JP MorganInitiate Overweight
2025-07-14CitigroupInitiate Buy
2021-06-30Keefe, Bruyette & WoodsDowngrade Outperform -> Market Perform
2021-06-21William BlairDowngrade Outperform -> Market Perform
2021-06-18B. Riley SecuritiesDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.02
Revenue Estimate
212.39M
Revenue Q2Q
75.65%
EPS Q2Q
N/A
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-0.06%
Revenue (3 Months)
2.07%
EPS (1 Month)
26.83%
EPS (3 Months)
29.15%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 2.07% in the past 3 months.

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CAI revenue by date.CAI revenue by date.
306.128M
-24.35%
412.26M
34.67%
812.033M
96.97%
1.017B
25.24%
1.244B
22.32%
1.454B
16.88%
1.633B
12.31%
1.842B
12.80%
1.922B
4.34%
EBITDA
YoY % growth
CAI ebitda by date.CAI ebitda by date.
-270.55M-208.209M
23.04%
67.728M
132.53%
167.18M
146.84%
259.66M
55.32%
350.79M
35.10%
485.25M
38.33%
555.55M
14.49%
656.8M
18.23%
EBIT
YoY % growth
CAI ebit by date.CAI ebit by date.
-319.551M-257.122M
19.54%
45.113M
117.55%
87.902M
94.85%
184.52M
109.92%
266.35M
44.35%
361.88M
35.87%
464.63M
28.39%
474.2M
2.06%
Operating Margin
CAI operating margin by date.CAI operating margin by date.
-104.38%-62.37%5.56%8.64%14.83%18.32%22.16%25.22%24.67%
EPS
YoY % growth
CAI eps by date.CAI eps by date.
N/A
-18.46%
N/A
-3.52%
N/A
-128.65%
0.13
106.30%
0.37
193.11%
0.64
72.68%
0.73
13.64%
0.86
18.06%
N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.020.03
100.38%
0.07
-15.46%
0.10
-64.84%
0.05
319.66%
0.10
229.38%
0.13
91.48%
0.16
58.31%
Revenue
Q2Q % growth
212.39M
75.65%
251.28M
38.52%
263.78M
21.65%
289.45M
-1.17%
272.53M
28.32%
311.63M
24.02%
317.9M
20.52%
340.3M
17.57%
EBITDA
Q2Q % growth
21.534M
142.30%
40.716M
997.82%
51.131M
0.32%
59.599M
-46.32%
49.126M
128.13%
68.68M
68.68%
79.224M
54.94%
85.85M
44.05%
EBIT
Q2Q % growth
-1.782M
96.92%
16.361M
190.95%
27.963M
-14.33%
35.824M
-59.48%
25.346M
1,522.14%
42.583M
160.27%
51.511M
84.21%
56.688M
58.24%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CAI Yearly Revenue VS EstimatesCAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
CAI Yearly EPS VS EstimatesCAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.27%
EPS Next 5 Year
-19.81%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.04%
Revenue Next 5 Year
17.18%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
606.33%
EBIT Next 5 Year
254.13%

CARIS LIFE SCIENCES INC / CAI Forecast FAQ

What is the price target for CAI stock?

14 analysts have analysed CAI and the average price target is 32.92 USD. This implies a price increase of 55.64% is expected in the next year compared to the current price of 21.15.

Can you provide the consensus estimates for CARIS LIFE SCIENCES INC next earnings?

The consensus EPS estimate for the next earnings of CARIS LIFE SCIENCES INC (CAI) is -0.02 USD and the consensus revenue estimate is 212.39M USD.

What is the expected long term growth rate for CARIS LIFE SCIENCES INC (CAI)?

The expected long term growth rate for CARIS LIFE SCIENCES INC (CAI) is 5.04%.